Phibro Animal Health: stocks, financial statements

Disable ads for free
Dividends News
Favorites

Manufactures and markets animal health pharmaceutical and nutritional products

  • PAHC Ticker
  • NASDAQ Exchange
  • 1,500 Employees
2 rated
  • $19.43, +$0.14 (+0.73%) Previous Close
  • 47,865 Previous Volume
  • $16.33 / $27.82 52 week low / high
  • -30.16% Percent off 52 week high
  • 2020-11-27 Updated
  • 2.47% Dividend Yield (trailing)
  • 2.47% Dividend Yield (forward)
  • 0 Public float
  • 20,287,574 Outstanding shares
  • 8.84 P/E
  • 383.23 M Market Cap
Disable ads for free

Financial statements — Phibro Animal Health

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 15 2020 2019 2018 2017 2016 2015
Total Revenue
800M 830M 820M 760M 750M 750M
Cost Of Revenue
540M 560M 550M 520M 510M 510M
Gross Profit
260M 260M 270M 250M 240M 240M
Research and Development
14M 12M 10M 9.4M 11M 9.5M
Selling General and Admin
170M 160M 160M 150M 140M 140M
Operating Expense
730M 740M 720M 670M 660M 660M
Operating Income
73M 87M 98M 92M 89M 88M
Other Income Expense Net
-18M -16M -9.8M -12M -12M -8.9M
EBIT
73M 87M 98M 92M 89M 88M
Interest Income
14M 14M 14M 17M 17M 15M
Pretax Income
56M 72M 88M 81M 77M 79M
Income Tax
22M 17M 23M 16M -6M 18M
Minority Interest
0 0 0 0 0 0
Net Income
34M 55M 65M 65M 83M 60M
Net Income Basic
34M 55M 65M 65M 83M 60M
20 ← 15 2020 2019 2018 2017 2016 2015
Current cash
36M 58M 29M 56M 34M 29M
Short term investments
55M 24M 50M 2.7M 3M 490K
Receivables
130M 160M 140M 130M 130M 110M
Inventory
200M 200M 180M 160M 170M 150M
Other current assets
37M 27M 22M 18M 15M 23M
Current assets
450M 470M 420M 360M 340M 310M
Long term investments
10M 9.6M 14M 9.3M 9.4M 9.5M
Property plant equipment
170M 140M 130M 130M 130M 100M
Goodwill
53M 27M 27M 24M 21M 13M
Intangible assets
71M 47M 52M 55M 60M 37M
Other assets
16M 19M 17M 16M 17M 11M
Total assets
780M 730M 670M 620M 610M 490M
Accounts payable
66M 73M 59M 57M 60M 63M
Current long term debt
19M 13M 13M 6.3M 2.8M 2.8M
Other current liabilities
62M 62M 68M 50M 44M 45M
Total current liabilities
160M 150M 140M 120M 110M 110M
Long term debt
390M 310M 300M 310M 350M 290M
Other liabilities
32M 23M 26M 29M 26M 16M
Minority Interest
0 0 0 0 0 0
Total Liabilities
600M 510M 490M 470M 520M 460M
Common stock
40M 40M 40M 40M 39M 39M
Retained earning
180M 170M 130M 83M 34M -37M
Treasury stock
80K 70K 41K 55K 83K 37K
Capital surplus
140M 130M 130M 120M 120M 120M
Shareholder equity
190M 220M 180M 150M 90M 30M
Net tangible assets
-55M 56M 26M 2.2M -53M -68M
20 ← 15 2020 2019 2018 2017 2016 2015
Net Income
34M 55M 65M 65M 83M 60M
Depreciation
32M 28M 27M 26M 23M 21M
Changes in receivables
33M -23M -3.5M -3.5M -14M
Changes in inventories
-13M -21M -24M 5.4M -16M -19M
Cash change
-21M 28M -27M 22M 4.4M 17M
Cash flow
59M 47M 70M 98M 37M 69M
Capital expenditures
-34M -30M -19M -21M -36M -20M
Investments
-31M 26M -50M
Investing activity other
-800K -400K -1.1M -1.1M -4M
Total investing cash flows
-120M -14M -85M -22M -83M -34M
Dividends paid
-19M -19M -16M -16M -16M -16M
Net borrowings
60M 13M -1.4M -43M 62M -1.1M
Other financing cash flows
Cash flow financing
41M -4.1M -12M -54M 50M -15M
Exchange rate effect
-1.1M -520K -540K -230K -420K -1.5M
Disable ads for free
Disable ads for free